US 9624229
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted A61PA61P29/00A61P35/00
Quick answer
US patent 9624229 (Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P35/02, A61P37/06